Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px

Document › Details

GenSight Biologics S.A.. (6/23/17). "Press Release: GenSight Biologics Successfully Raises €22.5 Million from Leading Investors in the US and Europe [Not for distribution in Canada, Australia and Japan]". Paris.

	Organisation	GenSight Biologics S.A. (Euronext: SIGHT)
	Organisation 2	INSTITUTIONAL INVESTOR/S
	Group	OTHER
	Product	lenadogene nolparvovec (GS010)
	Product 2	investment banking
	Index term	GenSight Biologics–SEVERAL: investment, 201706 capital increase €22.5m €6/share with Europ + US institutional investors
	Person	Gidoin, Thomas (GenSight Biologics 201507 CFO)
	Person 2	Janic, Marion (RooneyPartners 201702 Partner joined 2008)

Original document
accessed by [iito] on 2017-06-26

Record changed: 2023-06-05

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for GenSight Biologics S.A. (Euronext: SIGHT)

[1] GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris....
[2] GenSight Biologics S.A.. (4/3/18). "Press Release: GenSight Biologics Announces Topline Results from REVERSE Phase III Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)". Paris....
[3] GenSight Biologics S.A.. (8/1/17). "Press Relase: GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy". Paris....
[4] GenSight Biologics S.A.. (7/28/17). "Press Relase: GenSight Biologics Reports Interim Financial Results for the First Half of 2017". Paris....
[5] Reuters. (6/23/17). "News: BRIEF – Gensight Biologics Raises 22.5 Million Euros"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]